Subscribe
Sign in
Mediterrania portfolio company Laprophan…
Jun 26
The Moroccan pharmaceutical group has acquired a controlling stake in Switzerland-based Rivopharm.
Read →
Comments
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Mediterrania portfolio company Laprophan…
The Moroccan pharmaceutical group has acquired a controlling stake in Switzerland-based Rivopharm.